Methadone serum concentration and its relationship to methadone dose revisited

Heroin Addiction and Related Clinical Problems

Volumn 7, Issue 4, 2005, Pages 49-57

  Okruhlica, Lubomir ^a   Valentova, Jindra ^b   Devinsky, Ferdinand ^b   Formakova, Sona ^b   Klempova, Danica ^b  

^a Institut Drogovych Zavislosti   (Slovakia)

^b NONE

Author keywords

Linear relationship; Methadone dose; Methadone maintenance; Serum methadone concentration

Indexed keywords

METHADONE;

ADULT; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; CORRELATION ANALYSIS; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG DEPENDENCE TREATMENT; DRUG DETERMINATION; FEMALE; GAS CHROMATOGRAPHY; HUMAN; MAJOR CLINICAL STUDY; MALE; METHADONE TREATMENT; PRIORITY JOURNAL; STATISTICAL MODEL;

EID: 30444451027     PISSN: 15921638     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. BELL, J., SERES, V., BOWRON P., LEWIS, J., BATEY, R. (1988). The use of methadone levels in patients receiving methadone maintenance. Clinical Pharamcology and Therapy. 43(6): 623-629.
2. BYRNE, A. (1998). Use of serum Levels for Optimising Doses in Methadone Maintenance Treatment. Journal of Maintenance in the Addictions. 1(3): 13-14.
3. CHARLIER, C., DESSALLES, M. C., PLOMTEUX, G. (2001). Methadone maintenance treatment: is it possible to adapt the daily doses to metabolic activity of the patient? Therapeutic Drug Monitoring. 23(1): 1-3.
4. DE VOS, J.W., GEERLINGS, P.J., VAN DEN BRINK, W., UFKES, J.G.R., VAN WILGENBURG, H. (1995). Pharmocokinetics of methadone and its primary metabolite in 20 opiate addicts. European Journal of Clinical Pharmacology. 48(5): 361-366,
5. DOLE, V.P. (1988) Implications of methadone maintenance for theories of narcotic addiction. Journal of the American Medical Association. (260): 3025-3029.
6. EAP, C.B., FINKBEINER, T., GASTPAR, M., SCHERBAUM, M., POWELL, K., BAUMANN, P. (1996): Replacement of (R)-methadone by a double dose of (R,S)-methadone in addicts: interindividual variability of the (R/S) ratios and evidence of adaptive changes in methadone pharmacokinetics. Eur. J. Clin. Pharmacol. 50: 385-389.
7. EAP, C.B., BERTSCHY, G., BAUMANN, P., FINKBEINER, T., GASTPAR, M., SCHERBAUM, N. (1998). Interindividual Variability of Methadone Enantiomer Blood Levels to Dose Ratios. Archives of General Psychiatry. 55(1): 89-90.
8. EAP, C.B., DÉGLON, J.J., BAUMAN, P. (1999). Pharmacokinetics and Pharmacogenetics of Methadone: Clinical Relevance. Heroin Add. & Clin. Probl. 1(1): 19-34.9.
9. HORNS, W.H., RADO, M., GOLDSTEIN A. (1975). Plasma levels and symptom complaints in patients maintained on daily dosage of methadone hydrochloride. Clinical Pharmacology and Therapy. 17(6): 636-649.
10. INTURRISI, C.E., VEREBELY, K. (1972). The levels of methadone in the plasma in methadone maintenance. Clinical Pharmacology and Therapeutics. 13(5): 633-637.
11. KELL, J.M. (1995). Utilization of Plasma and Urine Methadone Concentration Measurements to Limit Narcotic Use in Methadone Maintenance Patients: II. Generation of Plasma Concentration Response Curves. Journal of Addictive Diseases. 14(1): 85-108.
12. KREEK, M.J. (1973). Plasma and urine levels of methadone. Comparison following four medication forms used in chronic maintenance treatment. New York State Journal of Medicine. 73(23): 2773-2777.
13. LEAVITT, S.B., SCHINDERMAN, M., MAXWELL, S., EAP, C.B., PARIS, P. (2000). When "Enough" is Not Enough: New Perspectives on Optimal Methadone Maintenance Dose. Mount Sinai Journal of Medicine. 67(5-6): 404-411.
14. LOIMER, N., SCHMID, R.(1992). The use of plasma levels to optimize methadone maintenance treatment. Drug and Alcohol Dependence. 30(3): 241-246.
15. Nicolaou, K., Wollf, K., Winstock, A., Finch, E., Strang, J. (2000). The influence of body weight on the kinetics of methadone. International Harm Reduction Conference (Poster, Book of Abstracts), New Jersey.
16. NILSSON, M.I., WIDERLOV, E., MERESAAR, U., ANGGARD, E. (1982). Effect of urinary pH on the disposition of methadone in man. European Journal of Clinical Pharmacology. 22(4): 337-342.
17. OKRUHLICA, L., DEVINSKY, F., VALENTOVA, J., KLEMPOVA, D. (2002). Does therapeutic threshold of methadone concentration in plasma exist? Heroin Add. & Rel. Clin. Probl. 4(1): 29-36.
18. PAYTE, J.T., KHURI, E.T. (1993). Principles of methadone dose determination. In: State Methadone Treatment Guidelines. Rockville, Md: US Dept of Health and Human Services, 47-58.
19. PLUMMER, J.L., GOURLAY, G.K., CHERRY, D.A. COUSINS, M.J. (1998). Estimation of methadone clearance: application in the management of cancer pain. Pain. 33(3): 313-322.
20. TENNANT, F.S. JR., RAWSON, R.A., COHEN, A., TARVER, A., CLABOUGH, D. (1983). Methadone plasma levels and persistent drug abuse in high dose maintenance patients. Subst. Alcohol Actions Misuse. 4(5): 369-374.
21. TENNANT, F.S. (1987). Inadequate Plasma Concentrations in Some High-Dose Methadone Maintenance Patients. American Journal of Psychiatry. 144(10): 1349-1350.
22. TORRENS, M., CASTILLO, C., SAN, L., DEL MORAL, E., GONZALES, M.L., DE LA TORE, R. (1998). Plasma methadone concentrations as an indicator of opioid withdrawal symptoms and heroin use in a methadone maintenance program. Drug and Alcohol Dependendence. 52(7): 193-200.
23. WOLFF, K., SANDERSON, M., HAY, A.W.M., RAISTRICK, D. (1991). Methadone concentrations in plasma and their relationship to drug dosage. Clinical Chemistry. 37(3): 205-209.
24. WOLFF, K., SANDERSON, M., HAY, A.W.M., RAISTRICK, D. (1991). Methadone concentrations in plasma and their relationship to drug dosage. Comment in: Clinical Chemistry. 38(3): 438-439.
25. WOLFF, K., ROSTAMI-HODJEGAN, A., HAY, A.W., RAISTRICK, D., TUCKER, G. (2000). Population-based pharmacokinetic approach for methadone monitoring of opiate addicts: potential clinical utility. Addiction. 95(12): 1771-1783.